These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effects of octreotide on experimental orthostatic neurogenic hypotension]. Verwaerde P, Bordet R, Portolan G, Tran MA, Marques MA, Montastruc JL, Sénard JM. Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1097-1101. PubMed ID: 8949386 [Abstract] [Full Text] [Related]
4. Octreotide for orthostatic hypotension. Lamarre-Cliche M, Cusson J. Can J Clin Pharmacol; 1999 Aug; 6(4):213-5. PubMed ID: 10601755 [Abstract] [Full Text] [Related]
5. Treatment of orthostatic hypotension with dihydroergotamine and caffeine. Hoeldtke RD, Cavanaugh ST, Hughes JD, Polansky M. Ann Intern Med; 1986 Aug; 105(2):168-73. PubMed ID: 3729199 [Abstract] [Full Text] [Related]
6. [Management of severe orthostatic hypotension by head-up-tilt posture and administration of fludrocortisone]. Kardos A, Avramov K, Dongó A, Gingl Z, Kardos L, Rudas L. Orv Hetil; 1996 Oct 27; 137(43):2407-11. PubMed ID: 8992437 [Abstract] [Full Text] [Related]
8. Dihydroergotamine therapy in orthostatic hypotension due to psychotropic drugs. Thulesius O, Berlin E. Int J Clin Pharmacol Ther Toxicol; 1986 Sep 27; 24(9):465-7. PubMed ID: 2877953 [Abstract] [Full Text] [Related]
18. Dihydroergotamine therapy in symptomatic postural hypotension. Bajada S. Aust N Z J Med; 1979 Dec 28; 9(6):709-12. PubMed ID: 294931 [Abstract] [Full Text] [Related]
19. Orthostatic hypotension in the elderly: diagnosis and treatment. Gupta V, Lipsitz LA. Am J Med; 2007 Oct 28; 120(10):841-7. PubMed ID: 17904451 [Abstract] [Full Text] [Related]